In contrast, Netrin-1 treatments can enhance BBB marker expression both in vitro and in vivo [148, 192, 262] and reduce BBB leakage in mouse models of MS [262] and BBB breakdown [192], suggesting BBB protective effects of Netrin-1-Unc5B signaling. Here, NTN1 is linked to myeloid sarcoma.